top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.

Biblioteca

MARC Lista (tabellare)
Addictive substances and neurological disease : alcohol, tobacco, caffeine, and drugs of abuse in everyday lifestyles / / edited by Ronald Ross Watson, University of Arizona, Arizona Health Sciences Center, Tucson, AZ, USA, Sherma Zibadi, Department of Pathology, University of South Florida Medical School, Tampa, FL, USA
Addictive substances and neurological disease : alcohol, tobacco, caffeine, and drugs of abuse in everyday lifestyles / / edited by Ronald Ross Watson, University of Arizona, Arizona Health Sciences Center, Tucson, AZ, USA, Sherma Zibadi, Department of Pathology, University of South Florida Medical School, Tampa, FL, USA
Pubbl/distr/stampa London : , : Academic Press, an imprint of Elsevier, , [2017]
Descrizione fisica 1 online resource (xv, 398 pages) : illustrations (chiefly color)
Disciplina 616.8607
Collana Gale eBooks
Soggetto topico Substance abuse - Physiological aspects
Substance abuse - Psychological aspects
Drugs of abuse - Physiological effect
Nervous system - Diseases
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Acute ethanol-induced changes in microstructural and metabolite concentrations on the brain: noninvasive functional brain Imaging -- Prenatal alcohol exposure and neuroglial changes in neurochemistry and behavior in animal models -- Alcohol on histaminergic neurons of brain -- Antenatal alcohol and histological brain disturbances -- Alcohol intoxication and traumatic spinal cord injury: basic and clinical science -- Visual and auditory changes after acute alcohol ingestion -- Zebrafish models of alcohol addiction -- Effect of alcohol on the regulation of a-Synuclein in the human brain -- Consumption of ethanol and tissue changes in the central nervous system -- Ethanol consumption and cerebellar disorders -- Gene expression in CNS regions of genetic rat models of alcohol abuse -- Role of TLR4 in the ethanol-induced modulation of the autophagy pathway in the brain --Cholinergic signaling in ethanol reward -- Alcoholic neurological syndromes -- Frontal lobe dysfunction after developmental alcohol exposure: implications from animal models -- Ethanol's action mechanisms in the brain: from lipid general alterations to specific protein receptor binding -- Antioxidant vitamins and brain dysfunction in alcoholics -- Serotonin deficiency and alcohol use disorders -- Functional reorganization of reward- and habit-related brain networks in addiction -- Ethanol: neurotoxicity and brain disorders -- Functionally relevant brain alterations in polysubstance users: differences to monosubstance users, study challenges, and implications for treatment -- Deep brain stimulation: a possible therapeutic technique for treating refractory alcohol and drug addiction behaviors -- Understanding the roles of genetic and environmental influences on the neurobiology of nicotine use -- Tobacco smoke and nicotine: neurotoxicity in brain development -- Paradise lost: a new paradigm for explaining the interaction between neural and psychological changes in nicotine addiction patients -- Interactions of alcohol and nicotine: CNS sites and contributions to their co-abuse -- Role of basal forebrain in nicotine alcohol co-abuse -- Chronic and acute nicotine exposure versus placebo in smokers and nonsmokers: a systematic review of resting-state fMRI studies -- Novel psychoactive substances: a new behavioral and mental health threat -- Cholesterol and caffeine modulate alcohol actions on cerebral arteries and brain -- Sleep, caffeine, and physical activity in older adults -- Ketamine: neurotoxicity and neurobehavioral disorders -- Left/right hemispheric "unbalance" model in addiction.
Record Nr. UNINA-9910583095403321
London : , : Academic Press, an imprint of Elsevier, , [2017]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Alcohol, nutrition, and health consequences / / Ronald Ross Watson, Victor R. Preedy, Sherma Zibadi, editors
Alcohol, nutrition, and health consequences / / Ronald Ross Watson, Victor R. Preedy, Sherma Zibadi, editors
Edizione [1st ed. 2013.]
Pubbl/distr/stampa New York, : Humana Press, 2012, c2013
Descrizione fisica 1 online resource (571 p.)
Disciplina 613.2
Altri autori (Persone) WatsonRonald R (Ronald Ross)
PreedyVictor R
ZibadiSherma
Collana Nutrition and health series
Soggetto topico Alcohol - Physiological effect
Alcoholism - Treatment
ISBN 1-283-62481-8
9786613937261
1-62703-047-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Alcoholic and Nutrition: an Overview -- Genetics of alcohol metabolism -- Laboratory models available to study alcohol and nutrition -- Ethanol-induced lipid peroxidation and apoptosis in embryopathy -- Alcohol Use During Lactation: Effects on the Mother Infant Dyad -- Moderate alcohol administration: oxidative stress and nutritional status -- Alcohol use and abuse: Effects on Body Weight and body composition -- Alcohol Nutrition and health inequalities -- The effect of diet on protein modification by ethanol metabolites -- Vitamin B12 deficiency in alcoholics -- Alcohol American Indians/Alaskan Natives and Alcohol: Biology, Nutrition and Positive Programs -- Metabolism of Ethanol to Acetaldehyde in the Rat Mammary Tissue. Inhibitory Effects of Plant Polyphenols and Folic Acid -- Dietary zinc supplementation and prenatal ethanol exposure -- Tocotrienol and cognitive dysfunction induced by alcohol -- Soy Products Affecting Alcohol Absorption and Metabolism -- Oats supplementation and alcohol-induced oxidative tissue damage -- Fish oil n-3 fatty acids to prevent hippocampus and cognitive dysfunction in experimental alcoholism -- Alcohol in HIV and possible interactions with antiretroviral medications -- Popular energy drinks and alcohol -- The psychological synergistic effects of alcohol and caffeine -- Alcohol and Smoking: A correlation of use in youth? -- Are there Physiological Correlations between alcohol and tobacco use in adults? -- Alcohol, HIV/AIDS and Liver Disease -- Nutritional status, socioeconomic factors, alcohol and cataracts -- Alcohol Intake and High Blood Pressure -- Alcohol and dyslipidemia -- Dietary antioxidants in chronic alcoholic pancreatitis -- Alcohol consumption, lifestyle factors and risk of type 2 diabetes -- Alcohol, overweight, and obesity -- Nutrition alcohol and anorectic and bulimic adolescents -- Viral infections and cancer during alcohol use -- Ethanol and hepatocarcinogenesis -- Alcohol, diet and their interaction in colorectal and urinary tract tumors -- Alcohol, acetaldehyde and digestive tract cancer -- Alcohol Intake and Esophageal Cancer: Epidemiologic Evidence --  A Nutritional approach to prevent alcoholic liver disease -- Nutraceutical potential of indigenous plant foods and herbs for treatment of alcohol related Liver damage -- Alcohol and nutrition as risk factors for chronic liver disease -- Alcohol-related liver disease: Roles of insulin resistance, lipotoxic ceramide accumulation and endoplasmic reticulum stress --  Nutrition and alcoholic and non-alcoholic fatty liver disease: The significance of cholesterol -- Dietary fatty acids and alcoholic liver disease -- Nutrition in alcoholic steatohepatitis -- Alcoholic and non-alcoholic fatty liver disease and vitamin A.
Record Nr. UNINA-9910438130003321
New York, : Humana Press, 2012, c2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Bioactive dietary factors and plant extracts in dermatology / / Ronald Ross Watson, Sherma Zibadi, editors
Bioactive dietary factors and plant extracts in dermatology / / Ronald Ross Watson, Sherma Zibadi, editors
Edizione [1st ed. 2013.]
Pubbl/distr/stampa New York, : Springer, 2013
Descrizione fisica 1 online resource (538 p.)
Disciplina 616.50654
Altri autori (Persone) WatsonRonald R (Ronald Ross)
ZibadiSherma
Collana Nutrition and health series
Soggetto topico Skin - Cancer
Functional foods - Therapeutic use
Cancer - Prevention
Dietary supplements - Therapeutic use
Cancer - Diet therapy
ISBN 1-283-91215-5
1-62703-167-7
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto pt. I. Overview -- pt. II. Dietary nutrients and skin -- pt. III. Plant and plant components and skin care -- pt. IV. Dietary components and skin health -- pt. V. Essential nutrients and skin cancer -- pt. VI. Dietary components and skin cancer -- pt. VII. Plants and plant components and non-cancerous skin diseases.
Record Nr. UNINA-9910437986703321
New York, : Springer, 2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Bioactive food as dietary interventions for arthritis and related inflammatory diseases [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
Bioactive food as dietary interventions for arthritis and related inflammatory diseases [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
Edizione [1st ed.]
Pubbl/distr/stampa Boston, : Elsevier, 2013
Descrizione fisica xxv, 654 p. : ill. (some col.)
Disciplina 616/.0473
Altri autori (Persone) WatsonRonald R (Ronald Ross)
PreedyVictor R
Collana Bioactive foods in chronic disease states
Soggetto topico Arthritis - Nutritional aspects
Inflammation
Bioactive compounds
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910795189703321
Boston, : Elsevier, 2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Bioactive food as dietary interventions for cardiovascular disease [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
Bioactive food as dietary interventions for cardiovascular disease [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
Edizione [1st ed.]
Pubbl/distr/stampa Boston, : Elsevier, 2013
Descrizione fisica 1 online resource (722 p.)
Disciplina 613.2
Altri autori (Persone) WatsonRonald R (Ronald Ross)
PreedyVictor R
Collana Bioactive foods in chronic disease states
Soggetto topico Cardiovascular system - Diseases - Nutritional aspects
Bioactive compounds
Soggetto genere / forma Electronic books.
ISBN 1-283-71650-X
0-12-396540-3
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front Matter; Bioactive Food as Dietary Interventions for CardiovascularDisease; Copyright; Contents; Preface: Bioactive Food for Cardiovascular Disease; Contributors; Chapter 1: Omega-3 Fatty Acids in Prevention of Cardiovascular Disease in Humans: Intervention Trials, Healthy Heart Conce...; 1. Introduction; 2. Role of Omega-3 Fatty Acids in CVD; 2.1. Role of Omega Fatty Acids in Dietary Fat and Vascular Health; 2.2. Role of Omega-3 Fatty Acids in CVD Prevention; 2.3. Therapeutic Lifestyle Changes Diet: A Multifaceted Lifestyle Approach to Reduce Risk of CHD
2.4. Omega-Fatty-Acid-Rich Functional Foods and CVD Risk2.5. Cardioprotective Effects of Omega-3 Fatty Acids; 2.6. Who Needs Initial Treatment with Omega-3 Fatty Acid Supplementation?; 2.7. Safety and Efficacy of Omega Fatty Acid Therapy in Infants, Children, and Adolescents; 3. Modern View of Omega Fatty Acid Therapy in CVD; 3.1. National Guidelines; 3.2. Mechanisms; 3.3. Clinical Trials to Modify Residual Cardiovascular Risk by LDL Cholesterol Lowering; 3.3.1. Saturated fatty acids; 3.3.2. Trans fatty acids; 3.3.3. Dietary cholesterol; 3.3.4. Monounsaturated fatty acids; 3.3.5. Wild foods
3.3.6. Supplementation of omega-3 fatty acids in combinatorial therapy4. Healthy Heart Concept: Less-Known Facts on Omega Fatty Acids; 4.1. Ancient Tribals: Indian Kurichiyas; 4.2. Australian Tribals; 4.3. Greenlandic Eskimos; 4.4. Dietary Fat Intake and Fatty Acid Ratio; 4.4.1. Columbus concept; 4.4.2. Oxidative stress and fatty acid ratio; 5. Guidelines on Omega Fatty Acid in CVD to Physicians, Nurses: Healthy Heart Concept; 5.1. Omega Fatty Acids in CHD: Treating Beyond LDL-C; 6. Implications and Futuristic Prospective; 7. Conclusions; Acknowledgments; References
Chapter 2: Herbal Supplements or Herbs in Heart Disease: History, Herbal Foods, Coronary Heart Disease1. Introduction; 1.1. Symptoms of Coronary Heart Disease; 1.2. Biochemical Basis of CHD; 1.2.1. Acute ischemic heart disease; 1.2.2. Congestive heart failure; 1.3. Diagnosis of CHD; 1.3.1. Acute coronary syndrome; 1.3.2. Congestive heart failure; 1.4. Scientific Basis of Herbal Therapy of Heart Disease; 1.4.1. Herbal supplements that open blood vessels; 1.4.2. Supplements that strengthen the heart muscle; 1.4.3. Heart disease and dietary supplements: antioxidants
1.4.4. Chinese herbs in reduction of HDL catabolism2. Relation to TG Metabolism; 3. Herbal Foods: Approved Herbs in Cardiovascular Disease; 3.1. Garlic: The Most-Studied Herbal Food for the Cardiovascular System; 3.2. Hawthorn, Gentle Heart Herb; 3.3. Lemon and Soy, Isoflavanoids; 3.4. Scutellaria, Panacea; 3.5. Radix Salviae Miltiorrhizae, Danshen Herbal Extract; 4. Repertory of Herbs and Their Properties; 5. Herbs in Human Use; 6. Cardioprotective Herb Active Components in Human Use Approved by CDC and Regulated by FDA; 6.1. Biochemical Basis of Herbiceuticals in Cardiac Prevention
7. Conclusion
Record Nr. UNINA-9910462209603321
Boston, : Elsevier, 2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Bioactive food as dietary interventions for cardiovascular disease [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
Bioactive food as dietary interventions for cardiovascular disease [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
Edizione [1st ed.]
Pubbl/distr/stampa Boston, : Elsevier, 2013
Descrizione fisica 1 online resource (722 p.)
Disciplina 613.2
Altri autori (Persone) WatsonRonald R (Ronald Ross)
PreedyVictor R
Collana Bioactive foods in chronic disease states
Soggetto topico Cardiovascular system - Diseases - Nutritional aspects
Bioactive compounds
ISBN 1-283-71650-X
0-12-396540-3
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front Matter; Bioactive Food as Dietary Interventions for CardiovascularDisease; Copyright; Contents; Preface: Bioactive Food for Cardiovascular Disease; Contributors; Chapter 1: Omega-3 Fatty Acids in Prevention of Cardiovascular Disease in Humans: Intervention Trials, Healthy Heart Conce...; 1. Introduction; 2. Role of Omega-3 Fatty Acids in CVD; 2.1. Role of Omega Fatty Acids in Dietary Fat and Vascular Health; 2.2. Role of Omega-3 Fatty Acids in CVD Prevention; 2.3. Therapeutic Lifestyle Changes Diet: A Multifaceted Lifestyle Approach to Reduce Risk of CHD
2.4. Omega-Fatty-Acid-Rich Functional Foods and CVD Risk2.5. Cardioprotective Effects of Omega-3 Fatty Acids; 2.6. Who Needs Initial Treatment with Omega-3 Fatty Acid Supplementation?; 2.7. Safety and Efficacy of Omega Fatty Acid Therapy in Infants, Children, and Adolescents; 3. Modern View of Omega Fatty Acid Therapy in CVD; 3.1. National Guidelines; 3.2. Mechanisms; 3.3. Clinical Trials to Modify Residual Cardiovascular Risk by LDL Cholesterol Lowering; 3.3.1. Saturated fatty acids; 3.3.2. Trans fatty acids; 3.3.3. Dietary cholesterol; 3.3.4. Monounsaturated fatty acids; 3.3.5. Wild foods
3.3.6. Supplementation of omega-3 fatty acids in combinatorial therapy4. Healthy Heart Concept: Less-Known Facts on Omega Fatty Acids; 4.1. Ancient Tribals: Indian Kurichiyas; 4.2. Australian Tribals; 4.3. Greenlandic Eskimos; 4.4. Dietary Fat Intake and Fatty Acid Ratio; 4.4.1. Columbus concept; 4.4.2. Oxidative stress and fatty acid ratio; 5. Guidelines on Omega Fatty Acid in CVD to Physicians, Nurses: Healthy Heart Concept; 5.1. Omega Fatty Acids in CHD: Treating Beyond LDL-C; 6. Implications and Futuristic Prospective; 7. Conclusions; Acknowledgments; References
Chapter 2: Herbal Supplements or Herbs in Heart Disease: History, Herbal Foods, Coronary Heart Disease1. Introduction; 1.1. Symptoms of Coronary Heart Disease; 1.2. Biochemical Basis of CHD; 1.2.1. Acute ischemic heart disease; 1.2.2. Congestive heart failure; 1.3. Diagnosis of CHD; 1.3.1. Acute coronary syndrome; 1.3.2. Congestive heart failure; 1.4. Scientific Basis of Herbal Therapy of Heart Disease; 1.4.1. Herbal supplements that open blood vessels; 1.4.2. Supplements that strengthen the heart muscle; 1.4.3. Heart disease and dietary supplements: antioxidants
1.4.4. Chinese herbs in reduction of HDL catabolism2. Relation to TG Metabolism; 3. Herbal Foods: Approved Herbs in Cardiovascular Disease; 3.1. Garlic: The Most-Studied Herbal Food for the Cardiovascular System; 3.2. Hawthorn, Gentle Heart Herb; 3.3. Lemon and Soy, Isoflavanoids; 3.4. Scutellaria, Panacea; 3.5. Radix Salviae Miltiorrhizae, Danshen Herbal Extract; 4. Repertory of Herbs and Their Properties; 5. Herbs in Human Use; 6. Cardioprotective Herb Active Components in Human Use Approved by CDC and Regulated by FDA; 6.1. Biochemical Basis of Herbiceuticals in Cardiac Prevention
7. Conclusion
Record Nr. UNINA-9910785961103321
Boston, : Elsevier, 2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Bioactive food as dietary interventions for diabetes [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
Bioactive food as dietary interventions for diabetes [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
Edizione [1st ed.]
Pubbl/distr/stampa Boston, : Elsevier, 2013
Descrizione fisica 1 online resource (659 p.)
Disciplina 613.2
Altri autori (Persone) WatsonRonald R (Ronald Ross)
PreedyVictor R
Collana Bioactive foods in chronic disease states
Soggetto topico Diabetes - Nutritional aspects
Bioactive compounds
Soggetto genere / forma Electronic books.
ISBN 1-283-71647-X
0-12-397762-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front Cover; Bioactive Food as Dietary Interventions for Diabetes; Copyright; Contents; Preface: Diabetes Food; Contributors; Chapter 1: Role of Oxidative Stress in the Pathogenesis of Insulin Resistance and Type 2 Diabetes; 1. Introduction; 2. Systemic Glucose Homeostasis is a Multiorgan Process; 3. Glucose Dysregulation: The Pathogenesis of Insulin Resistance; 4. Origins of Oxidative Stress in Various Cell Types; 4.1. Renin-Angiotensin System and NADPH Oxidase; 4.2. Nutrient Excess and Mitochondrial Overactivity; 4.3. Hyperglycemia; 4.4. Dyslipidemia: Role of Excess FFAs
4.5. Endoplasmic Reticulum Stress4.6. Additional Role of Nitrosative Stress; 5. Mechanisms of Oxidative Stress-Associated Insulin Resistance; 5.1. Oxidative Stress and Defects in Insulin Signaling: Skeletal Muscle and Liver; 5.2. Oxidative Stress and Defects in Insulin Secretion: Pancreatic Beta-Cells; 5.3. Oxidative Stress and Defects in Vascular Function; 6. Utility of Select Antioxidants as Interventions in Oxidative Stress-Associated Insulin Resistance; 6.1. General Concepts of Antioxidant Properties; 6.2. ALA and Its Effects on Glucoregulation; 7. Conclusion and Perspectives
AcknowledgmentsReferences; Relevant Websites; Chapter 2: Diabetes and the Role of Dietary Supplements; 1. Introduction; 2. Alpha-Lipoic Acid; 3. Omega-3 Oils; 4. Chromium; 5. Gymnemma Sylvestre; 6. Fenugreek; 7. Vitamin D; 8. Conclusion; Glossary; References; Chapter 3: Government Regulation of Dietary Supplements and Foods: Role in Diabetes; 1. Introduction; 2. Nongovernmental Recommendations for Diabetics; 3. NHPs for Diabetics; 4. Food Label Information and Nutrition - Health Claims; 5. Nutrition Recommendations for Diabetics; 6. Conclusions; References
Chapter 4: Diabetes as an Immune Dysfunction Syndrome1. Diagnostic Laboratory Testing; 1.1. First-Line Assessments; 1.1.1. Glucose and insulin levels; 1.1.2. HbA1c; 1.2. Additional Testing; 1.2.1. C-octanoic acid breath test; 1.2.2. C-peptide; 1.2.3. C-reactive protein (hsCRP); 1.2.4. Cortisol and DHEA; 1.2.5. Lymphocyte Response Assay (LRA) tests; 1.2.6. Fibrinogen; 1.2.7. Homocysteine; 1.2.8. Insulin-like growth factor binding protein-1; 1.2.9. Intestinal hyperpermeability test; 1.2.10. Iron and ferritin; 1.2.11. Oxidized LDL (oxLDL); 1.2.12. Metabolic acidosis risk
1.2.13. Sleep survey or evaluation2. Key Clinical Issues; 2.1. Energy Metabolism; 2.1.1. Glucose; 2.1.2. Fructose; 2.1.3. Protein metabolism in diabetes; 2.1.4. Fat metabolism; 2.2. Autonomic Neuropathy; 2.3. Immune Dysregulation and Increased Permeability; 2.4. Maldigestion; 2.4.1. Reflux; 2.4.2. Dyspepsia; 2.4.3. Dysbiosis; 2.4.4. Malabsorption; 2.4.5. Delayed gastric emptying; 2.5. Autacoids: Profound Biochemical Effects; 3. Diagnoses and Comorbidities; 3.1. Prevalent Comorbidities; 3.1.1. Vascular sequella and neurodegeneration; 3.1.2. Hyperlipidemia and hypertension
3.1.3. Kidney disease
Record Nr. UNINA-9910462229203321
Boston, : Elsevier, 2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Bioactive food as dietary interventions for diabetes [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
Bioactive food as dietary interventions for diabetes [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
Edizione [1st ed.]
Pubbl/distr/stampa Boston, : Elsevier, 2013
Descrizione fisica 1 online resource (659 p.)
Disciplina 613.2
Altri autori (Persone) WatsonRonald R (Ronald Ross)
PreedyVictor R
Collana Bioactive foods in chronic disease states
Soggetto topico Diabetes - Nutritional aspects
Bioactive compounds
ISBN 1-283-71647-X
0-12-397762-2
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front Cover; Bioactive Food as Dietary Interventions for Diabetes; Copyright; Contents; Preface: Diabetes Food; Contributors; Chapter 1: Role of Oxidative Stress in the Pathogenesis of Insulin Resistance and Type 2 Diabetes; 1. Introduction; 2. Systemic Glucose Homeostasis is a Multiorgan Process; 3. Glucose Dysregulation: The Pathogenesis of Insulin Resistance; 4. Origins of Oxidative Stress in Various Cell Types; 4.1. Renin-Angiotensin System and NADPH Oxidase; 4.2. Nutrient Excess and Mitochondrial Overactivity; 4.3. Hyperglycemia; 4.4. Dyslipidemia: Role of Excess FFAs
4.5. Endoplasmic Reticulum Stress4.6. Additional Role of Nitrosative Stress; 5. Mechanisms of Oxidative Stress-Associated Insulin Resistance; 5.1. Oxidative Stress and Defects in Insulin Signaling: Skeletal Muscle and Liver; 5.2. Oxidative Stress and Defects in Insulin Secretion: Pancreatic Beta-Cells; 5.3. Oxidative Stress and Defects in Vascular Function; 6. Utility of Select Antioxidants as Interventions in Oxidative Stress-Associated Insulin Resistance; 6.1. General Concepts of Antioxidant Properties; 6.2. ALA and Its Effects on Glucoregulation; 7. Conclusion and Perspectives
AcknowledgmentsReferences; Relevant Websites; Chapter 2: Diabetes and the Role of Dietary Supplements; 1. Introduction; 2. Alpha-Lipoic Acid; 3. Omega-3 Oils; 4. Chromium; 5. Gymnemma Sylvestre; 6. Fenugreek; 7. Vitamin D; 8. Conclusion; Glossary; References; Chapter 3: Government Regulation of Dietary Supplements and Foods: Role in Diabetes; 1. Introduction; 2. Nongovernmental Recommendations for Diabetics; 3. NHPs for Diabetics; 4. Food Label Information and Nutrition - Health Claims; 5. Nutrition Recommendations for Diabetics; 6. Conclusions; References
Chapter 4: Diabetes as an Immune Dysfunction Syndrome1. Diagnostic Laboratory Testing; 1.1. First-Line Assessments; 1.1.1. Glucose and insulin levels; 1.1.2. HbA1c; 1.2. Additional Testing; 1.2.1. C-octanoic acid breath test; 1.2.2. C-peptide; 1.2.3. C-reactive protein (hsCRP); 1.2.4. Cortisol and DHEA; 1.2.5. Lymphocyte Response Assay (LRA) tests; 1.2.6. Fibrinogen; 1.2.7. Homocysteine; 1.2.8. Insulin-like growth factor binding protein-1; 1.2.9. Intestinal hyperpermeability test; 1.2.10. Iron and ferritin; 1.2.11. Oxidized LDL (oxLDL); 1.2.12. Metabolic acidosis risk
1.2.13. Sleep survey or evaluation2. Key Clinical Issues; 2.1. Energy Metabolism; 2.1.1. Glucose; 2.1.2. Fructose; 2.1.3. Protein metabolism in diabetes; 2.1.4. Fat metabolism; 2.2. Autonomic Neuropathy; 2.3. Immune Dysregulation and Increased Permeability; 2.4. Maldigestion; 2.4.1. Reflux; 2.4.2. Dyspepsia; 2.4.3. Dysbiosis; 2.4.4. Malabsorption; 2.4.5. Delayed gastric emptying; 2.5. Autacoids: Profound Biochemical Effects; 3. Diagnoses and Comorbidities; 3.1. Prevalent Comorbidities; 3.1.1. Vascular sequella and neurodegeneration; 3.1.2. Hyperlipidemia and hypertension
3.1.3. Kidney disease
Record Nr. UNINA-9910785961003321
Boston, : Elsevier, 2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Bioactive food as dietary interventions for liver and gastrointestinal disease [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
Bioactive food as dietary interventions for liver and gastrointestinal disease [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
Edizione [1st ed.]
Pubbl/distr/stampa Boston, : Elsevier, 2013
Descrizione fisica 1 online resource (801 p.)
Disciplina 613.2
Altri autori (Persone) WatsonRonald R (Ronald Ross)
PreedyVictor R
Collana Bioactive foods in chronic disease states
Soggetto topico Gastrointestinal system - Diseases - Nutritional aspects
Liver - Diseases - Nutritional aspects
Bioactive compounds
Soggetto genere / forma Electronic books.
ISBN 1-283-71646-1
0-12-397764-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front Cover; Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease; Copyright; Contents; Preface: Liver and Gastrointestinal Health; Contributors; Chapter 1: The Alkaline Way in Digestive Health; 1. Dietary Factors in Metabolism; 1.1. Profile: Metabolic Acidosis as a Major Cause of Chronic Disease; 1.1.1. Associated signs and symptoms; 1.1.1.1 Fatigue; 1.1.1.2 Osteopenia and osteoporosis; 1.1.2. Relevant evaluations; 1.1.2.1 Self-evaluation: Testing for pH; 1.1.2.2 Laboratory evaluation: Reducing immune reactivity; 1.1.3. Clinical interventions: the alkaline way
1.1.3.1 Alkaline diet1.1.3.1.1. Enhancing immune defenses; 1.1.3.1.2. Buffering cellular chemistry; 1.1.3.2 Alkaline nutrients; 1.1.3.2.1. Buffering minerals; 1.1.3.2.2. Buffering fats; 1.1.4. Individual essential nutritional supplementation; 1.1.4.1 Antioxidants: Ascorbate to zinc; 1.1.4.2 B-complex vitamins to support methylation; 2. Glycemic Load as a Tool for Better Digestive andCardiovascular Management; 2.1. Associated Signs and Symptoms; 2.2. Self-evaluation; 2.2.1. Glycemic index: Older and less useful; 2.2.2. Glycemic load: Newer and more useful
2.3. Intervention: Low to Moderate Glycemic Diet3. Native Whey-Based Meals and Gastrointestinal Health; 4. Food Allergies and Sensitivities; 4.1. Associated Signs and Symptoms; 4.1.1. The link between allergies and digestive competence; 4.1.2. Lactose intolerance; 4.1.3. Gluten or casein intolerance or sensitivity; 4.2. Evaluation: LRA by ELISA/ACT Tests; 4.3. Intervention: Hypoallergenic Diet; 5. The Role of Specific Nutrients in Digestive Health; 6. Conclusion; References; Relevant Websites; Chapter 2: Functional Assessment of Gastrointestinal Health; 1. Physiology of Digestion
2. Clinical Issues in Digestive Health2.1. Profile: Dysbiosis; 2.1.1. Associated signs and symptoms; 2.1.2. Etiology; 2.1.2.1 Sidebar: initial probiotic research; 2.1.3 Intervention: probiotic supplementation; 2.1.3.1 Benefits of microflora; 2.1.3.1.1. Production of digestive enzymes by microflora; 2.1.3.1.2. Reduced lipid levels; 2.1.3.1.3. Inhibition of pathogens; 2.1.3.2 Probiotic dosage; 2.1.3.2.1. Preventive applications; 2.1.3.2.2. Therapeutic interventions; 2.1.3.2.3. Medical probiotics; 2.2. Profile: Hyperpermiability (Leaky Gut Syndrome); 2.2.1. Associated signs and symptoms
2.2.2. Intervention: recycled glutamine supplementation2.3. Profile: Allergic Reactions as a Cause and Effect of Leaky Gut; 2.3.1. Hyperpermeability as a cause of reactivity; 2.3.2. Allergies as a cause of hyperpermeability; 2.4. Profile: Maldigestion and Enteropathy; 2.4.1. Comorbidities; 2.4.2. Cause and Consequences; 2.4.2.1 Low enzyme levels; 2.4.2.2 Poorly timed gastric emptying; 2.4.2.3 Surgical restructuring of the GI tract; 2.4.2.4 Malabsorption; 2.4.2.5 Enteropathy; 2.5. Transit Time; 2.5.1. Associated signs and symptoms; 2.5.1.1 Delayed transit time; 2.5.1.2 Rapid transit time
2.5.2. Evaluation: self-test for transit time
Record Nr. UNINA-9910462230003321
Boston, : Elsevier, 2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Bioactive food as dietary interventions for liver and gastrointestinal disease [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
Bioactive food as dietary interventions for liver and gastrointestinal disease [[electronic resource] /] / edited by Ronald Ross Watson and Victor R. Preedy
Edizione [1st ed.]
Pubbl/distr/stampa Boston, : Elsevier, 2013
Descrizione fisica 1 online resource (801 p.)
Disciplina 613.2
Altri autori (Persone) WatsonRonald R (Ronald Ross)
PreedyVictor R
Collana Bioactive foods in chronic disease states
Soggetto topico Gastrointestinal system - Diseases - Nutritional aspects
Liver - Diseases - Nutritional aspects
Bioactive compounds
ISBN 1-283-71646-1
0-12-397764-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Front Cover; Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease; Copyright; Contents; Preface: Liver and Gastrointestinal Health; Contributors; Chapter 1: The Alkaline Way in Digestive Health; 1. Dietary Factors in Metabolism; 1.1. Profile: Metabolic Acidosis as a Major Cause of Chronic Disease; 1.1.1. Associated signs and symptoms; 1.1.1.1 Fatigue; 1.1.1.2 Osteopenia and osteoporosis; 1.1.2. Relevant evaluations; 1.1.2.1 Self-evaluation: Testing for pH; 1.1.2.2 Laboratory evaluation: Reducing immune reactivity; 1.1.3. Clinical interventions: the alkaline way
1.1.3.1 Alkaline diet1.1.3.1.1. Enhancing immune defenses; 1.1.3.1.2. Buffering cellular chemistry; 1.1.3.2 Alkaline nutrients; 1.1.3.2.1. Buffering minerals; 1.1.3.2.2. Buffering fats; 1.1.4. Individual essential nutritional supplementation; 1.1.4.1 Antioxidants: Ascorbate to zinc; 1.1.4.2 B-complex vitamins to support methylation; 2. Glycemic Load as a Tool for Better Digestive andCardiovascular Management; 2.1. Associated Signs and Symptoms; 2.2. Self-evaluation; 2.2.1. Glycemic index: Older and less useful; 2.2.2. Glycemic load: Newer and more useful
2.3. Intervention: Low to Moderate Glycemic Diet3. Native Whey-Based Meals and Gastrointestinal Health; 4. Food Allergies and Sensitivities; 4.1. Associated Signs and Symptoms; 4.1.1. The link between allergies and digestive competence; 4.1.2. Lactose intolerance; 4.1.3. Gluten or casein intolerance or sensitivity; 4.2. Evaluation: LRA by ELISA/ACT Tests; 4.3. Intervention: Hypoallergenic Diet; 5. The Role of Specific Nutrients in Digestive Health; 6. Conclusion; References; Relevant Websites; Chapter 2: Functional Assessment of Gastrointestinal Health; 1. Physiology of Digestion
2. Clinical Issues in Digestive Health2.1. Profile: Dysbiosis; 2.1.1. Associated signs and symptoms; 2.1.2. Etiology; 2.1.2.1 Sidebar: initial probiotic research; 2.1.3 Intervention: probiotic supplementation; 2.1.3.1 Benefits of microflora; 2.1.3.1.1. Production of digestive enzymes by microflora; 2.1.3.1.2. Reduced lipid levels; 2.1.3.1.3. Inhibition of pathogens; 2.1.3.2 Probiotic dosage; 2.1.3.2.1. Preventive applications; 2.1.3.2.2. Therapeutic interventions; 2.1.3.2.3. Medical probiotics; 2.2. Profile: Hyperpermiability (Leaky Gut Syndrome); 2.2.1. Associated signs and symptoms
2.2.2. Intervention: recycled glutamine supplementation2.3. Profile: Allergic Reactions as a Cause and Effect of Leaky Gut; 2.3.1. Hyperpermeability as a cause of reactivity; 2.3.2. Allergies as a cause of hyperpermeability; 2.4. Profile: Maldigestion and Enteropathy; 2.4.1. Comorbidities; 2.4.2. Cause and Consequences; 2.4.2.1 Low enzyme levels; 2.4.2.2 Poorly timed gastric emptying; 2.4.2.3 Surgical restructuring of the GI tract; 2.4.2.4 Malabsorption; 2.4.2.5 Enteropathy; 2.5. Transit Time; 2.5.1. Associated signs and symptoms; 2.5.1.1 Delayed transit time; 2.5.1.2 Rapid transit time
2.5.2. Evaluation: self-test for transit time
Record Nr. UNINA-9910785961303321
Boston, : Elsevier, 2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui